The B.E. Journal of Economic Analysis & Policy
Editor-in-Chief: Jürges, Hendrik / Ludwig, Sandra
Ed. by Auriol , Emmanuelle / Brunner, Johann / Fleck, Robert / Friebel, Guido / Mendola, Mariapia / Requate, Till / Tsui, Kevin / Wichardt, Philipp / Zulehner, Christine
4 Issues per year
IMPACT FACTOR 2014: 0.336
5-year IMPACT FACTOR: 0.848
SCImago Journal Rank (SJR) 2014: 0.633
Source Normalized Impact per Paper (SNIP) 2014: 0.606
Impact per Publication (IPP) 2014: 0.640
Volume 15 (2015)
Volume 14 (2014)
Volume 12 (2012)
Volume 11 (2011)
Volume 9 (2009)
Volume 6 (2006)
Volume 4 (2004)
Volume 2 (2002)
Volume 1 (2001)
Most Downloaded Articles
- The Inheritance of Educational Inequality: International Comparisons and Fifty-Year Trends by Hertz, Tom/ Jayasundera, Tamara/ Piraino, Patrizio/ Selcuk, Sibel/ Smith, Nicole and Verashchagina, Alina
- IQ and Family Background: Are Associations Strong or Weak? by Björklund, Anders/ Hederos Eriksson, Karin and Jäntti, Markus
- Do Rising Top Income Shares Affect the Incomes or Earnings of Low and Middle-Income Families? by Thompson, Jeffrey P. and Leight, Elias
- Therapeutic Equivalence and the Generic Competition Paradox by Nabin, Munirul Haque/ Mohan, Vijay/ Nicholas, Aaron and Sgro, Pasquale M.
- Economic Decision-Making in Poverty Depletes Behavioral Control by Spears, Dean
The Shape of Demand: What Does It Tell Us about Direct-to-Consumer Marketing of Antidepressants?
1Agency for Healthcare Research and Quality, (email)
2Agency for Healthcare Research and Quality, (email)
Citation Information: The B.E. Journal of Economic Analysis & Policy. Volume 8, Issue 2, ISSN (Online) 1935-1682, DOI: 10.2202/1935-1682.1805, January 2008
- Published Online:
Much of the debate surrounding Direct-to-Consumer Advertising (DTCA) of pharmaceuticals centers on whether DTCA conveys useful information to consumers or indiscriminately increases requests for the advertised medication. By identifying how DTCA changes the shape of the demand curve for antidepressants, we seek to infer the promotional objectives of manufacturers. Using data from the 1996-2003 Medical Expenditure Panel Survey (MEPS), we find that advertising shifts the demand curve for antidepressants outward and rotates it counter-clockwise. DTCA increases the probability that an individual will initiate use of antidepressants, particularly when out-of-pocket medication costs are low, but does not necessarily increase utilization levels among those already taking antidepressants. This is consistent with a promotional campaign that seeks to alert consumers to the product's existence, but conveys no real information that would allow them to learn their true match with the product.
Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.